Literature DB >> 33525523

Magnesium Oxide in Constipation.

Hideki Mori1, Jan Tack1, Hidekazu Suzuki2.   

Abstract

Magnesium oxide has been widely used as a laxative for many years in East Asia, yet its prescription has largely been based on empirical knowledge. In recent years, several new laxatives have been developed, which has led to a resurgence in interest and increased scientific evidence surrounding the use of magnesium oxide, which is convenient to administer, of low cost, and safe. Despite these advantages, emerging clinical evidence indicates that the use of magnesium oxide should take account of the most appropriate dose, the serum concentration, drug-drug interactions, and the potential for side effects, especially in the elderly and in patients with renal impairment. The aim of this review is to evaluate the evidence base for the clinical use of magnesium oxide for treating constipation and provide a pragmatic guide to its advantages and disadvantages.

Entities:  

Keywords:  constipation; hypermagnesemia; laxative; magnesium oxide

Year:  2021        PMID: 33525523      PMCID: PMC7911806          DOI: 10.3390/nu13020421

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  62 in total

1.  The use of Epsom salts, historically considered.

Authors:  R D Rudolf
Journal:  Can Med Assoc J       Date:  1917-12       Impact factor: 8.262

Review 2.  Current and future therapies for chronic constipation.

Authors:  J Tack
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-02       Impact factor: 3.043

Review 3.  Naloxegol , a new drug for the treatment of opioid-induced constipation.

Authors:  Maura Corsetti; Jan Tack
Journal:  Expert Opin Pharmacother       Date:  2014-12-13       Impact factor: 3.889

4.  Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation.

Authors:  Ling-Nan Bu; Mei-Hwei Chang; Yen-Hsuan Ni; Huey-Ling Chen; Chia-Chi Cheng
Journal:  Pediatr Int       Date:  2007-08       Impact factor: 1.524

5.  Efficacy and safety of naloxegol in patients with opioid-induced constipation and laxative-inadequate response.

Authors:  Jan Tack; Jaakko Lappalainen; Ulysses Diva; Raj Tummala; Mark Sostek
Journal:  United European Gastroenterol J       Date:  2015-10       Impact factor: 4.623

Review 6.  New treatments and therapeutic targets for IBS and other functional bowel disorders.

Authors:  Magnus Simrén; Jan Tack
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-10       Impact factor: 46.802

Review 7.  Milk-alkali syndrome.

Authors:  Boris I Medarov
Journal:  Mayo Clin Proc       Date:  2009-03       Impact factor: 7.616

8.  Primary Care Management of Chronic Constipation in Asia: The ANMA Chronic Constipation Tool.

Authors:  Kok-Ann Gwee; Uday C Ghoshal; Sutep Gonlachanvit; Andrew Seng Boon Chua; Seung-Jae Myung; Shaman Rajindrajith; Tanisa Patcharatrakul; Myung-Gyu Choi; Justin C Y Wu; Min-Hu Chen; Xiao-Rong Gong; Ching-Liang Lu; Chien-Lin Chen; Nitesh Pratap; Philip Abraham; Xiao-Hua Hou; Meiyun Ke; Jane D Ricaforte-Campos; Ari Fahrial Syam; Murdani Abdullah
Journal:  J Neurogastroenterol Motil       Date:  2013-04-16       Impact factor: 4.924

9.  Risk factors for the development of hypermagnesemia in patients prescribed magnesium oxide: a retrospective cohort study.

Authors:  Eri Wakai; Kenji Ikemura; Hiroko Sugimoto; Takuya Iwamoto; Masahiro Okuda
Journal:  J Pharm Health Care Sci       Date:  2019-02-13

10.  A Randomized Double-blind Placebo-controlled Trial on the Effect of Magnesium Oxide in Patients With Chronic Constipation.

Authors:  Sumire Mori; Toshihiko Tomita; Kazuki Fujimura; Haruki Asano; Tomohiro Ogawa; Takahisa Yamasaki; Takashi Kondo; Tomoaki Kono; Katsuyuki Tozawa; Tadayuki Oshima; Hirokazu Fukui; Takeshi Kimura; Jiro Watari; Hiroto Miwa
Journal:  J Neurogastroenterol Motil       Date:  2019-10-30       Impact factor: 4.924

View more
  3 in total

Review 1.  Pharmacotherapy and the Role of Pharmacists in Rehabilitation Medicine.

Authors:  Yoshihiro Yoshimura; Ayaka Matsumoto; Ryo Momosaki
Journal:  Prog Rehabil Med       Date:  2022-05-14

2.  Effects of Elobixibat in Patients with Diabetes and Concomitant Chronic Constipation: an 8-week, Prospective, Single-center, Single-arm Study.

Authors:  Yoshiaki Hishida; Yoshio Nagai; Hidekazu Tsukiyama; Yuta Nakamura; Tomoko Nakagawa; Sonoko Ishizaki; Yasushi Tanaka; Masakatsu Sone
Journal:  Adv Ther       Date:  2022-07-22       Impact factor: 4.070

3.  Effects of Elobixibat on Constipation and Lipid Metabolism in Patients With Moderate to End-Stage Chronic Kidney Disease.

Authors:  Momoko Matsuyama; Keiji Hirai; Hiroaki Nonaka; Moeka Ueda; Junki Morino; Shohei Kaneko; Saori Minato; Yuko Mutsuyoshi; Katsunori Yanai; Hiroki Ishii; Taisuke Kitano; Akinori Aomatsu; Haruhisa Miyazawa; Kiyonori Ito; Yuichiro Ueda; Susumu Ookawara; Yoshiyuki Morishita
Journal:  Front Med (Lausanne)       Date:  2022-01-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.